| Code | 25931 | ||||||||||
| MA number | 29/0836/96-S | ||||||||||
| Product Form: | tbl 20x15 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Boehringer Ingelheim International GmbH, Germany | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 29.10.1996 |
| Pediatric contraindication: | Yes |
| SPC: |
SPC_Movalis 15 mg_12.2023.pdf
|
| PIL: |
PIL_Movalis 15 mg_12.2023.pdf
|
| Safety feature | Yes |
| Data update: | 30.05.2018 |
